Your browser doesn't support javascript.
loading
Patient Experience with Chronic Refractory Gout and Its Impact on Health-Related Quality of Life: Literature Review and Qualitative Analysis.
Strand, Vibeke; Pillinger, Michael H; Oladapo, Abiola; Yousefian, Charis; Brooks, Dani; Kragh, Nana.
Affiliation
  • Strand V; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.
  • Pillinger MH; NYU Grossman School of Medicine, 550 First Avenue, New York City, NY, 10016, USA.
  • Oladapo A; Sobi Inc., 77 4th Avenue, Waltham, MA, 02451, USA.
  • Yousefian C; Endpoint Outcomes, a Lumanity company, 280 Summer St., 8th Floor, Boston, MA, 02210, USA.
  • Brooks D; Endpoint Outcomes, a Lumanity company, 280 Summer St., 8th Floor, Boston, MA, 02210, USA.
  • Kragh N; Sobi, SE-112 76, Stockholm, Sweden. nana.kragh@sobi.com.
Rheumatol Ther ; 11(5): 1271-1290, 2024 Oct.
Article in En | MEDLINE | ID: mdl-39098965
ABSTRACT

INTRODUCTION:

Patients with chronic refractory gout face a considerable burden of disease due to unexpected flares characterized by severe and debilitating pain, which can lead to chronic pain and joint damage. This study aimed to understand the symptoms and impacts of chronic refractory gout on health-related quality of life (HRQoL).

METHODS:

A targeted literature review was conducted to identify and review key articles describing the symptoms and impacts of gout, and articles examining the psychometric performance of the Medical Outcomes Survey Short Form-36 (SF-36) and Health Assessment Questionnaire-Disability Index (HAQ-DI) in gout. Qualitative interviews were conducted with 20 participants with chronic refractory gout. The results were used to develop the conceptual model and determine the appropriateness of the SF-36 and HAQ-DI in evaluating HRQoL in this population.

RESULTS:

Most frequently reported symptoms included bodily pain (n = 18, 90.0%), joint swelling (n = 18, 90.0%), joint tenderness (n = 18, 90.0%), and joint pain (n = 16, 80.0%). Most frequently reported impacts were difficulties climbing a flight (n = 20, 100.0%) or several flights of stairs (n = 20, 100.0%), climbing five steps (n = 19, 95.0%), completing chores (n = 19, 95.0%), and running errands and shopping (n = 19, 95.0%). All assessed items from SF-36 and HAQ-DI were reported by ≥ 25% (n = 5) of participants and mapped sufficiently to concepts elicited by participants.

CONCLUSIONS:

Patients with chronic refractory gout report symptoms and impacts that are highly bothersome and burdensome to everyday life. Items included in the HAQ-DI and SF-36 mapped directly to these symptoms and impacts and are relevant to understand the burden of disease of chronic refractory gout.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Rheumatol Ther Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Rheumatol Ther Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido